We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$204B
AUM Growth
+$40.7B
Cap. Flow
+$14.4B
Cap. Flow %
7.02%
Top 10 Hldgs %
15.11%
Holding
4,579
New
569
Increased
2,381
Reduced
1,060
Closed
261

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$845M
2
TME icon
Tencent Music
TME
+$643M
3
BIDU icon
Baidu
BIDU
+$528M
4
TSLA icon
Tesla
TSLA
+$476M
5
AMZN icon
Amazon
AMZN
+$391M

Sector Composition

Rank Sector Weight
1 Technology 13.51%
2 Consumer Discretionary 9.39%
3 Healthcare 9.23%
4 Communication Services 7.28%
5 Financials 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPKI
4126
NPK International
NPKI
$1.15B
$51K ﹤0.01%
26,380
+10,503
+66% +$14.1K
SCOR icon
4127
Comscore
SCOR
$113M
$50K ﹤0.01%
1,004
+364
+57% +$16.2K
SIEN
4128
DELISTED
Sientra, Inc.
SIEN
$50K ﹤0.01%
+1,301
New +$58.3K
SREV
4129
DELISTED
ServiceSource International, Inc.
SREV
$48K ﹤0.01%
+27,579
New +$40.8K
BNTC icon
4130
Benitec Biopharma
BNTC
$451M
$47K ﹤0.01%
916
HBIO icon
4131
Harvard Bioscience
HBIO
$27.9M
$47K ﹤0.01%
+1,091
New +$40.7K
BTU icon
4132
Peabody Energy
BTU
$2.87B
$45K ﹤0.01%
18,549
-49,327
-73% -$80K
LVO icon
4133
LiveOne
LVO
$56.9M
$45K ﹤0.01%
+1,387
New +$33.8K
IMDX
4134
Insight Molecular Diagnostics
IMDX
$155M
$45K ﹤0.01%
+939
New +$34.5K
DS
4135
DELISTED
Drive Shack Inc.
DS
$44K ﹤0.01%
+18,751
New +$33.2K
KIN
4136
DELISTED
Kindred Biosciences, Inc.
KIN
$44K ﹤0.01%
+10,305
New +$41.9K
AAIC
4137
DELISTED
Arlington Asset Investment Corp.
AAIC
$42K ﹤0.01%
+10,934
New +$34.2K
OSG
4138
DELISTED
Overseas Shipholding Group Inc.
OSG
$41K ﹤0.01%
+18,855
New +$39.3K
RESN
4139
DELISTED
Resonant Inc.
RESN
$41K ﹤0.01%
+15,280
New +$36.1K
TLSA icon
4140
Tiziana Life Sciences
TLSA
$124M
$40K ﹤0.01%
+20,000
New +$63.2K
TPST icon
4141
Tempest Therapeutics
TPST
$14.4M
$40K ﹤0.01%
97
+2
+2% +$691
QUAD icon
4142
Quad
QUAD
$515M
$39K ﹤0.01%
+10,241
New +$31.4K
APTX
4143
DELISTED
Aptinyx Inc. Common Stock
APTX
$39K ﹤0.01%
+11,233
New +$39.1K
CKPT
4144
DELISTED
Checkpoint Therapeutics
CKPT
$38K ﹤0.01%
+1,425
New +$36.1K
PXLW icon
4145
Pixelworks
PXLW
$40.6M
$38K ﹤0.01%
+1,117
New +$33.7K
FRBK
4146
DELISTED
Republic First Bancorp Inc
FRBK
$37K ﹤0.01%
+12,948
New +$34.3K
SLNO
4147
DELISTED
Soleno Therapeutics
SLNO
$36K ﹤0.01%
+1,236
New +$35.7K
SRGA
4148
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$36K ﹤0.01%
+549
New +$35.8K
GLEO.WS
4149
CALL
DELISTED
Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share
GLEO.WS
$36K ﹤0.01%
42,500
-25,000
-37% -$15.6K
III icon
4150
Information Services Group
III
$239M
$34K ﹤0.01%
+10,253
New +$26.8K

Similar funds

Credit Suisse's Q4 2020 Portfolio in Review

As of Q4 2020, Credit Suisse held 4,579 positions worth $204B, up 25% from $164B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $14.4B of net new capital in Q4 2020, opening 569 new positions and adding to 2,381 existing holdings. Its largest new stake was Palantir: 6,341,206 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $546M trimmed.

  • Credit Suisse's largest Q4 2020 buy was Palantir: 6,341,206 shares worth $149M.
  • Credit Suisse added most to Alibaba in Q4 2020, an estimated $845M increase.
  • Credit Suisse's biggest Q4 2020 reduction was UnitedHealth, cutting an estimated $546M.
  • Credit Suisse fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $260M.
  • Credit Suisse's ten largest holdings make up 15% of its $204B portfolio in Q4 2020.
  • Credit Suisse opened 569 new positions and closed 261 in Q4 2020.
  • Credit Suisse's portfolio value rose 25% quarter-over-quarter to $204B.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.